Correlation Between Bayer AG and Bristol Myers

Can any of the company-specific risk be diversified away by investing in both Bayer AG and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bayer AG and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bayer AG and Bristol Myers Squibb, you can compare the effects of market volatilities on Bayer AG and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bayer AG with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bayer AG and Bristol Myers.

Diversification Opportunities for Bayer AG and Bristol Myers

-0.17

Correlation Coefficient

Bayer AG  Bristol Myers

Good diversification

The 3 months correlation between Bayer and Bristol is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Bayer AG and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Bayer AG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bayer AG are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Bayer AG i.e., Bayer AG and Bristol Myers go up and down completely randomly.

Pair Corralation between Bayer AG and Bristol Myers

Assuming the 90 days horizon Bayer AG is expected to under-perform the Bristol Myers. But the pink sheet apears to be less risky and, when comparing its historical volatility, Bayer AG is 1.98 times less risky than Bristol Myers. The pink sheet trades about -0.08 of its potential returns per unit of risk. The Bristol Myers Squibb is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  97,195  in Bristol Myers Squibb on June 21, 2024 and sell it today you would lose (23,645) from holding Bristol Myers Squibb or give up 24.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	59.04%
Values	Daily Returns

Bayer AG  vs.  Bristol Myers Squibb

Bayer AG

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bayer AG are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Bayer AG may actually be approaching a critical reversion point that can send shares even higher in October 2024.

Bristol Myers Squibb

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol Myers may actually be approaching a critical reversion point that can send shares even higher in October 2024.

Pair Trading with Bayer AG and Bristol Myers

The main advantage of trading using opposite Bayer AG and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bayer AG position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.

The idea behind Bayer AG and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..